Overview of Triglyceride Levels and Estimated VLDL in Atherosclerosis Development among Patients over 50 Years
DOI:
10.29303/jbt.v26i3.12789Published:
2026-08-02Downloads
Abstract
Atherosclerosis is a chronic arterial disease caused by disorders of lipid metabolism, leading to the formation of atherosclerotic plaques. Elevated triglyceride levels are associated with increased production of Very Low-Density Lip oprotein (VLDL), which plays an important role in the process of atherogenesis and contributes to an increased risk of cardiovascular disease. Therefore, the measurement of triglyceride levels and the estimation of VLDL are important for the early detection of atherosclerosis risk, particularly in patients aged over 50 years. This study aimed to describe triglyceride levels and VLDL estimation in relation to atherosclerosis formation among patients aged over 50 years at QIM Batang Hospital. This study employed a descriptive research design involving 27 patients aged over 50 years. Triglyceride levels were measured using the enzymatic colorimetric GPO-PAP method with a chemistry analyzer, while VLDL levels were estimated using the Friedewald formula (VLDL = triglycerides/5). Data were analyzed descriptively and presented as frequency distributions and percentages. The laboratory results showed that normal triglyceride levels were found in 10 respondents (37.04%), borderline-high triglyceride levels in 10 respondents (37.04%), and high triglyceride levels in 7 respondents (25.92%). High estimated VLDL levels were observed in 17 respondents (62.96%), whereas normal estimated VLDL levels were found in 10 respondents (37.04%). These findings indicate that most patients aged over 50 years had elevated estimated VLDL levels, suggesting a potential increase in the risk of atherosclerosis development.
Keywords:
Atherosclerosis GPO-PAP Patients aged over 50 years Triglycerides Very low-density lipoprotein (VLDL)References
Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., Elkind, M. S. V., Evenson, K. R., Ferguson, J. F., Gupta, D. K., Kissela, B. M., Knutson, K. L., Lee, C. D., Lewis, T. T., Liu, J., Loop, M. S., ... Virani, S. S. (2021). Heart disease and stroke statistics—2021 update: A report from the American Heart Association. Circulation, 143(8), e254–e743. https://doi.org/10.1161/CIR.0000000000000950
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., Michos, E. D., Miedema, M. D., Muñoz, D., Smith, S. C., Virani, S. S., Williams, K. A., Yeboah, J., & Ziaeian, B. (2019). 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 140(11), e596–e646. https://doi.org/10.1161/CIR.0000000000000678
Ballena-Caicedo, J., Zuzunaga-Montoya, F. E., & Loayza-Castro, J. A. (2025). Global prevalence of dyslipidemias in the general adult population: A systematic review and meta-analysis. Archives of Public Health, 83, Article 3. https://doi.org/10.1186/s41043-025-01054-3
Borén, J., & Taskinen, M. R. (2021). Metabolism of triglyceride-rich lipoproteins. In Endotext. Springer Nature. https://doi.org/10.1007/164_2021_520
Castillo-Núñez, Y., Morales-Villegas, E., & Aguilar-Salinas, C. A. (2022). Triglyceride-rich lipoproteins: Their role in atherosclerosis. Archivos de Cardiología de México, 92(Suppl. 2), 61–70. https://doi.org/10.24875/RIC.21000416
Christie, W. W. (2021). Lipids. In Essentials of Food Chemistry (pp. 197–253). Springer. https://doi.org/10.1007/978-981-16-0610-6_5
Esan, O., & Wierzbicki, A. S. (2021). Triglycerides and cardiovascular disease. Current Opinion in Cardiology, 36(4), 469–472. https://doi.org/10.1097/HCO.0000000000000862
Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., Lewis, G. F., Lichtenstein, A. H., Moulin, P., Nordestgaard, B. G., Tybjærg-Hansen, A., & Stock, J. K. (2021). Triglyceride-rich lipoproteins and their remnants: Metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—A consensus statement from the European Atherosclerosis Society. European Heart Journal, 42(47), 4791–4806. https://doi.org/10.1093/eurheartj/ehab551
Hanun, M., Fatmah, & Sartika, R. A. D. (2020). Analisis faktor utama kadar trigliserida abnormal pada penduduk dewasa di Indonesia. Jurnal Delima Harapan, 7(2), 118–127. https://doi.org/10.31935/delima.v7i2.104
Heeren, J., & Scheja, L. (2021). Metabolic-associated fatty liver disease and lipoprotein metabolism. Molecular Metabolism, 50, 101238. https://doi.org/10.1016/j.molmet.2021.101238
Huang, J. (2022). Emerging evidence of pathological roles of very-low-density lipoprotein (VLDL). International Journal of Molecular Sciences, 23(8), 4300. https://doi.org/10.3390/ijms23084300
Ibarretxe, D., & Masana, L. (2021). Triglyceride metabolism and classification of hypertriglyceridemias. Clinical Investigation in Arteriosclerosis, 33(Suppl. 1), 1–6. https://doi.org/10.1016/j.arteri.2021.02.004
Langlois, M. R. (2025). The Friedewald formula strikes back. Clinical Chemistry and Laboratory Medicine, 63(6), 1043–1045. https://doi.org/10.1515/cclm-2025-0211
Libby, P. (2021). The changing landscape of atherosclerosis. Nature, 592(7855), 524–533. https://doi.org/10.1038/s41586-021-03392-8
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., Graham, I. M., Halliday, A., Landmesser, U., Mihaylova, B., Pedersen, T. R., Riccardi, G., Richter, D. J., Sabatine, M. S., Taskinen, M. R., ... ESC Scientific Document Group. (2020). 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. European Heart Journal, 41(1), 111–188. https://doi.org/10.1093/eurheartj/ehz455
Prasetyaningrum, Y. I. (2020). Pengaruh pemberian jus jamur tiram terhadap kadar kolesterol, trigliserida, dan malondialdehid penderita hiperkolesterolemia. Indonesian Journal of Clinical Nutrition, 16(3), 122–128. https://doi.org/10.22146/ijcn.40813
Purba, H. (2019). Pemeriksaan kadar trigliserida pada usia di atas 50 tahun di Rumah Sakit Umum Daerah Panyabungan Mandailing Natal. International Journal of Medical Laboratory, 2(1), 14–17.
Sascău, R., Clement, A., Radu, R., Prisacariu, C., & Stătescu, C. (2021). Triglyceride-rich lipoproteins and their remnants as silent promoters of atherosclerotic cardiovascular disease and other metabolic disorders: A review. Nutrients, 13(6), 1774. https://doi.org/10.3390/nu13061774
Spitler, K. M., & Davies, B. S. J. (2020). Aging and plasma triglyceride metabolism. Journal of Lipid Research, 61(8), 1161–1167. https://doi.org/10.1194/jlr.R120000922
Stahel, P., Xiao, C., Nahmias, A., Tian, L., & Lewis, G. F. (2021). Multiorgan control of triglyceride-rich lipoprotein metabolism by hormones, nutrients, and the autonomic nervous system. Endocrine Reviews, 42(6), 899–938. https://doi.org/10.1210/endrev/bnab008
Szychowska, A., & Drygas, W. (2022). Physical activity as a determinant of successful aging: A narrative review. Aging Clinical and Experimental Research, 34(6), 1209–1214. https://doi.org/10.1007/s40520-021-02037-0
Tsioulos, G., Kounatidis, D., Vallianou, N. G., Poulaki, A., Kotsi, E., Christodoulatos, G. S., Tsilingiris, D., Karampela, I., Skourtis, A., & Dalamaga, M. (2024). Lipoproteins and atherosclerotic cardiovascular disease: Where do we stand? International Journal of Molecular Sciences, 25(6), 3537. https://doi.org/10.3390/ijms25063537
Virani, S. S., Morris, P. B., Agarwala, A., Ballantyne, C. M., Birtcher, K. K., Kris-Etherton, P. M., Ladden-Stirling, A. B., Miller, M., Orringer, C. E., & Stone, N. J. (2021). 2021 ACC Expert Consensus Decision Pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: A report of the American College of Cardiology Solution Set Oversight Committee. Journal of the American College of Cardiology, 78(9), 960–993. https://doi.org/10.1016/j.jacc.2021.06.011
Vishakagorur. (2023). Atherosclerosis: Understanding the silent cardiovascular culprit. Journal of Stem Cell Research and Regenerative Medicine, 6(5), 115–116.
License
Copyright (c) 2026 Mohamad Zaul Haq, Bekti Mastiadji, Subur Wibowo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
